Podcast appearances and mentions of ian walters

Music is the medium, and helping students feel seen and valued is the goal. This is the fuel behind Maize Elementary School teacher Katie Todd's music instruction to kindergarten through fourth grade students. Katie earned her Bachelors of Music Education in 2012 from Kansas State University. She continued her education by pursuing a Masters of Music Education degree at her alma mater, graduating in 2017. Todd is in her twelfth year of teaching and currently teaches in Maize USD 266, where she is admired by colleagues, parents, and students alike.Katie finds much of the inspiration for lessons from her time spent with her two young daughters, Olivia and Charlotte, and her husband.Being a mother gives her insight into what families need from their educators to help them connect and bond. Additionally, she teaches private oboe lessons, is a New Teacher Mentor, and collaborates with Kansas State University to support new and future Elementary Music Teachers. In January of 2024 Todd was recognized as a Music for All: Advocacy in Action award winner for the Elementary Excellence category. She received this for her efforts over the past three years to connect students and their families with Kindie music artists through their grade level performances. She was also selected as the 2024 Elementary Teacher of the Year Nominee for USD266. In August of 2024 Katie released her first single Chickadee under the artist name “Katie T”. Her entrance into the Kindie music world came after encouragement received from friends and family as well as members of the Children's Music Network. She was fortunate to work with Bret Turner and Ian Walters of The Tallest Kid in the Room on this release. The song can be heard on all streaming platforms. Katie loves building relationships with her students and families and is passionate about helping them connect to each other and finding a deeper understanding of themselves through music. This quote can be found on the wall of her classroom: “ This is why I teach music…not because I expect you to major in music, not because I expect you to play or sing all your life, not so you can relax, not so you can have fun, but so you will be human, so you will recognize beauty, so you will be closer to an infinite beyond this world, so you will have something to clog to, so you will have more love, more compassion, more gentleness, more good. In short, more life.” - author unknownChickadee by Katie Todd

Despite the huge commercial success of PD-1 inhibitors and widespread use of checkpoint inhibitors such as anti-PD-1 or anti-CTLA4, 70 to 80% of patients still experience limited or no response to existing therapies.  In response to this critical challenge, Portage Biotech is on a mission to expand the number of patients who derive long-term benefits from immunotherapies.  Portage Biotech is advancing a portfolio of novel precision immuno-oncology therapies, including invariant natural killer T-cell (iNKT) engagers, designed to correct the tumor microenvironment and enable the body to recognize and attack tumors, and next-generation adenosine inhibitors for a variety of cancers, with better potency, selectivity and durability. Heading this pioneering endeavor is Dr. Ian Walters, Portage's CEO, who brings decades of experience in the immuno-oncology space. With a unique background as a physician with a business degree, Dr. Walters has been deeply involved in academia and large pharmaceutical companies. He played a pivotal role in the development of some of the first checkpoint inhibitors and has supported the approval of five oncology drugs.  In this conversation, Walters tells Labiotech about Portage's unique approach to targeting known checkpoint resistant pathways and the company's strategy to revolutionize immunotherapy research and drug development.

What happens when the “sideshow characters” of national politics are suddenly thrust onto the main stage? And in a post-Donald Trump Washington, where are they now?Read more:Ben Terris has spent years covering politics via the people on the fringe: operatives who aren't well known but are key to understanding how Washington works. When a former reality TV show host became president, suddenly some of those political oddballs were running things. Terris's book, “The Big Break: The Gamblers, Party Animals, and True Believers Trying to Win in Washington While America Loses Its Mind,” details the stories of people such as Sean McElwee, the pollster-turned-political-gambler who fell out of favor in Democratic circles, and Ian Walters, a longtime conservative communications director who broke with his closest friends after they staunchly backed Trump. In today's episode, Terris recounts the characters he met covering the Trump administration and how they've changed the face of power in Washington.

Our guest this week is Dr. Ian Walters, CEO of Portage Biotech. Dr. Juneja talks with Dr. Walters to explain how we can potentially educate our own immune system to kill cancer cells and then retain that education to prevent future recurrences. And what if we could create a drug to impact multiple cancers - via existing checkpoint inhibitors or pathways? Watch this episode to find out about the science that is being developed right now.

While many clinical-stage biopharmas are contracting or holding the line through the current market slump, Portage Biotech leaders Ian Walters, Allan Shaw, and company are making moves. The company recently acquired  Tarus Therapeutics and iOx Therapeutics Ltd., extending its pipeline and positioning itself to meet some aggressive investor expectations. On this episode of the Business of Biotech, Shaw dissects the deals, digging into the M&A strategy at Portage and offering advice from the batter's box to leaders of early-stage biotechs.

Portage Biotech (PRTG) researches and develops pharmaceutical and biotechnology products. Dr. Ian Walters, CEO of Portage Biotech, gives an overview of the company and the outlook for Portage Biotech. Portage Biotech partners with immune-oncology companies to guide novel cancer treatments through clinical development. Tune in to find out more.

Dr. Ian Walters' company, Portage Biotech, is focused on addressing the 75% of cancer patients who show no, or limited, response to existing therapies such as checkpoint inhibitors. Leading that charge are the company's invariant natural killer T cell agonists, designed to activate the innate and adaptive immune system, as well as a growing portfolio of proteins, antibodies, and small molecules. On this episode of the Business of Biotech, Dr. Walters shares what's fueling the company's progress, including its unique financing strategy and its approach to de-risking platform development for novel immuno oncology therapies.

Can T cells be leveraged as a cancer therapeutic? Check. How about natural killer (NK) cells? Check. Now meet invariant natural killer (iNKT) cells – a potentially game-changing tool to reprogram the innate and adaptive immune system to recognize and attack tumors. In this episode of the Benchtop Bios Podcast, leading life science entrepreneur and former Executive Director at Bristol-Myers Squibb, Dr. Ian Walters – now CEO of Portage Biotech – highlights the role iNKT cells play in activating the immune system and how Portage is leveraging these cells to advance novel cancer treatments.

While the class of immunotherapies known as checkpoint inhibitors has brought a promising new approach to treating cancer, the development of resistance to these therapies limits the number of patients they benefit. Portage Biotech is building a set of platform technologies and a pipeline of immuno-oncology therapeutic candidates to address this problem. We spoke to Ian Walters, CEO of Portage about the problem of resistance, the company's pipeline of candidates, and its portfolio-based business model.

Saluki Baseball Home Run King » Pro Ball Player  Nick Neville's bond with Ian Walters, the Itchy Jones Stadium experience & more in this podcast.

Saluki Baseball Home Run King » Pro Ball Player  Nick Neville's bond with Ian Walters, the Itchy Jones Stadium experience & more in this podcast.

Dr. Ian Walters is CEO of Portage Biotech is building a pipeline of novel immunotherapies for the treatment of cancer particularly for patients who do not respond to current therapies.  The key is stimulating a type of immune cell called invariant natural killer T-cell which works with the adaptive immune system to create a broad immune response and stronger immune surveillance to help stop cancer from forming in the body. Having contributed to bringing five new blockbuster cancer drugs to patients, Ian and his team are working to hit all key components for every different tumor type for a long-term response and possible cure.  They think their drug could have potential in settings that wouldn't respond to just pure NK cell therapy. #ImmunoOncology #Cancer #iNKT #biotech $PRTG PortageBiotech.com Listen to the podcast here

Dr. Ian Walters is CEO of Portage Biotech is building a pipeline of novel immunotherapies for the treatment of cancer particularly for patients who do not respond to current therapies.  The key is stimulating a type of immune cell called invariant natural killer T-cell which works with the adaptive immune system to create a broad immune response and stronger immune surveillance to help stop cancer from forming in the body. Having contributed to bringing five new blockbuster cancer drugs to patients, Ian and his team are working to hit all key components for every different tumor type for a long-term response and possible cure.  They think their drug could have potential in settings that wouldn't respond to just pure NK cell therapy. #ImmunoOncology #Cancer #iNKT #biotech $PRTG PortageBiotech.com Download the transcript here

201118 - Can the States Certify Their Results in Time? | DAVID SHESTOKAS | IAN WALTERS by Blanquita Cullum

201106 - Are All the Votes Legit? | DEROY MURDOCK | IAN WALTERS | PATRICK WOOD by Blanquita Cullum

The Airbus-built Solar Orbiter (SolO) is on an epic journey to unlock the Sun’s secrets. Listen to our latest podcast, which includes insights from Ian Walters, the Solar Orbiter Project Manager. Podcast topics include SoIO’s testing prior to launch in February 2020 and protecting the deep space probe from temperatures exceeding 500°C when it reaches the Sun’s vicinity.Ian Walter has been with Airbus since 1982. He has previously held positions of CTO / Chief Engineer for Galileo Industries, developing the complete Galileo navigation system for the EU, and Airbus VP for Navigation Systems, in Munich. He was also Engineering Manager for the Rosetta Platform and Project Manager for the JWST Mid Infra-red Instrument (MIRI).More info: https://www.airbus.com/newsroom/events/virtual-comms.html See acast.com/privacy for privacy and opt-out information.

Tune in to Episode 10 of the Saluki Standards Podcast with this week's guest, Ian Walters. The Saluki Baseball senior talks about making #SCTop10, having $4 to spend on dinner, and playing for a coach that jumps from airplanes.

Tune in to Episode 10 of the Saluki Standards Podcast with this week's guest, Ian Walters. The Saluki Baseball senior talks about making #SCTop10, having $4 to spend on dinner, and playing for a coach that jumps from airplanes.

Raw uncut audio from the Solar Orbiter Rollout Video featuring Airbus' Solar Orbiter Project Manager.  Warning: Problems may occur during unedited interview, including Co-Host inconsistencies, flubs and mechanical failures. 

Sebastian talks to CPAC's Ian Walters about why the crazies at InfoWars were kicked out of this year's conference, then talks to Katrina Pierson, in-studio, about the Trump 2020 campaign's incredible progress going into NovemberSupport the show: https://www.sebgorka.com/See omnystudio.com/listener for privacy information.

How do you completely rewrite the playbook for the recruiting industry while rapidly scaling your business? You focus on your values to help your people be the best they can be. That’s exactly what Gill Buchanan, COO, at Pure set out to do with her two partners, Lynn and Ian Walters. With their core values in hand (and evident everywhere in the company), they’ve created a people-centric workplace culture that really does put people first. Listen to Gill share how and why this works at Pure. About our guest: Gill has worked in the recruitment field since 1988 and co-founded Pure Resourcing. She continually ensures that Pure’s core values underpin their operations and make it a rewarding and positive place to work. For more on Pure Resourcing visit prs.uk.com; and find Gill on LinkedIn at linkedin.com/in/gillbuchanan/

Last Friday night, CPAC communications director Ian Walters made racially-charged remarks about Michael Steele at the conference's Ronald Reagan dinner. He said Michael was elected as RNC Chair "because he was a black guy". Michael and Rick responded to Walters' repulsive remarks Saturday morning and continued this conversation Monday night. Today, Mr. Walters wrote an op-ed in The Hill to defend and double-down on his comments, disparage Michael’s management of the RNC and bash “fake Republicans on MSNBC”. Michael and Rick respond to Walters' latest comment. The guys also discuss reports that foreign officials from China, Israel, Mexico and the United Arab Emirates discussed ways they could acquire leverage on and manipulate Jared Kushner.

CPAC communications director Ian Walters made racially charged and disparaging remarks about Michael Steele at the conference's Ronald Reagan dinner Friday night. Michael and Rick responded Saturday morning, talking with CPAC chairman Matt Schlapp and other guests about Walters’ repulsive remarks. The guys continue the conversation tonight. Both liberal and conservative pundits and politicians voiced their disgust about what Walters said. Michael explains how the conversations with Schlapp and Walters reflect his experience as a black Republican. Syndicated conservative columnist Mona Charen was booed at CPAC Saturday for calling out the hypocrisy of Republicans and conservatives supporting men who have been accused of sexual assault and sexual misconduct like Donald Trump and Roy Moore. She talks about the experience and how Trump has taken over the conservative movement.

The Mo'Kelly Show Presents – The disrespect and defense of Former RNC Chairman Michael Steele AND Regular Guest Commentator Johnny Wendell's thoughts on CPAC and the NRA plus Dr. Betty Uribe discusses Latina History Day 2018 AND Hot Wheels celebrates its 50th anniversary on KFI AM 640 – More Stimulating Talk!

Ian Walters, the communications director for CPAC, spoke at the Ronald Reagan dinner Friday night and said that Michael Steele was elected as RNC Chair because he was a black guy.Steele & Ungar was LIVE from CPAC Saturday morning to respond to Walters' ugly and repulsive comment.

Ian Walters and Sarah Lee talk about the Two Trumps, ACU Ratings Event on Capitol Hill, & Nerd Prom. Follow CPAC 365 on twitter @CPAC & @ACUConservative

Episode 162, Live at the Looking Glass with Katie Balloons, Anupama Pillalamarri and Ian Walters Katie Balloons, America's Favorite Balloon Girl, stops by the show to tell us about her passion and sing her theme song. Amazing. Anupama Pillalamarri is not the tallest person. To celebrate our last Looking Glass show, Ian Walters closed the […]

Cigarbox Planetarium "Blueberry Burns" From the album "Society of Rubber Cement". You, Me, Them, Everybody DC Music Podcast. January 27 You, Me, Them, Everybody Live! Hosted by Brandon Wetherbee guests include New Columbia Heights blogger Andrew Wiseman stand up comedian Seaton Smith a special set from Cigarbox Planetarium music from Ian Walters and more The […]

Week 2! Much better than week 1! The Prince of Petworth creator speaks highly of Washington DC. Michael Foody is amazing and, if the world is fair, will be very rich and successful. The Torches play music you want to drink to in a dive bar. Ian Walters plays piano throughout the evening. We all […]